Basics ADC Therapeutics SA IPO Date: May 18, 2020 Sector: Healthcare Industry: Biotech Market Cap: $127.94M Activated in VL: True Average Daily Range Avg Daily Range: $0.41 | 3.79% Avg Daily Range (30 D): $0.03 | 2.34% Avg Daily Range (90 D): $0.06 | 3.36% Institutional Daily Volume Avg Daily Volume: .38M Avg Daily Volume (30 D): .29M Avg Daily Volume (90 D): .41M Trade Size Avg Trade Size (Sh.): 142 Avg Trade Size (Sh.) (30 D): 147 Avg Trade Size (Sh.) (90 D): 149 Institutional Trades Total Inst.Trades: 287 Avg Inst. Trade: $1.34M Avg Inst. Trade (30 D): $.97M Avg Inst. Trade (90 D): $1.15M Avg Inst. Trade Volume: .16M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.39M Avg Closing Trade (30 D): $1.32M Avg Closing Trade (90 D): $1.32M Avg Closing Volume: 503.58K         News Oct 31, 2024 @ 4:57 PM Cancer Antibody Drug Conjugates Market, Drugs Appr... Source: Researchandmarkets.Com Aug 6, 2024 @ 10:51 PM ADC Therapeutics berichtet über Finanzergebniss... Source: Adc Therapeutics Jul 12, 2024 @ 10:40 AM Antibody Drug Conjugates Market Insights 2018-2023... Source: Researchandmarkets.Com Jul 2, 2024 @ 4:27 PM ADC Therapeutics gewährt neuen Mitarbeitern Zut... Source: ADC Therapeutics SA Jun 27, 2024 @ 4:23 PM ADC Therapeutics tritt demnächst den Indizes Ru... Source: ADC Therapeutics SA Financials   TTM Q4 2024 FY 2024 Basic EPS $-1.62 $-.27 $-1.62 Diluted EPS $-1.62 $-.27 $-1.62 Revenue $ 70.84M $ 16.91M $ 70.84M Gross Profit $ 64.89M $ $ 64.89M Net Income / Loss $ -157.85M $ -30.73M $ -157.85M Operating Income / Loss $ -130.65M $ -32.44M $ -130.65M Cost of Revenue $ 5.95M $ $ 5.95M Net Cash Flow $ -27.73M $ -23.41M $ -27.73M PE Ratio     Splits May 10, 2005:   7:1